Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Absci (ABSI) Amortizatization of Intangibles (2022 - 2026)

Absci (ABSI) posted Amortizatization of Intangibles of $421000.0 for Q1 2026, down 20.11% sequentially from $527000.0 in Q4 2025, and down 39.77% YoY from $699000.0 in Q1 2025.

Analysis

Absci (ABSI) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends

Absci has reported Amortizatization of Intangibles for 5 years, with the latest figure at $421000.0 in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 39.77% year-over-year to $421000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 40.57% YoY) and the FY2025 annual result came in at $2.5 million, down 32.06% from the prior year.
  • Amortizatization of Intangibles retreated to $421000.0 in Q1 2026 per ABSI's latest filing, from $527000.0 in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $1.2 million in Q2 2024 and troughed at $396000.0 in Q4 2023.
  • A 5-year average of $719000.0 and a median of $678500.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles jumped 97.47% in 2024, then slumped 44.8% in 2025.
  • Over 5 years, Amortizatization of Intangibles stood at $688000.0 in 2022, then plunged by 42.44% to $396000.0 in 2023, then surged by 97.47% to $782000.0 in 2024, then plunged by 32.61% to $527000.0 in 2025, then dropped by 20.11% to $421000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $421000.0, $527000.0, and $648000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Absci 1.39 Bn 1.19 Bn - 328,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 328,000.00
Mar 31, 2026 421,000.00
Dec 31, 2025 527,000.00
Sep 30, 2025 648,000.00
Jun 30, 2025 669,000.00
Mar 31, 2025 699,000.00
Dec 31, 2024 782,000.00
Sep 30, 2024 1.12 Mn
Jun 30, 2024 1.21 Mn
Mar 31, 2024 631,000.00
Dec 31, 2023 396,000.00
Sep 30, 2023 629,000.00
Jun 30, 2023 814,000.00
Mar 31, 2023 832,000.00
Dec 31, 2022 688,000.00